Expert Position
Physician focused on longevity and healthspan, host of The Drive
As of 2020 Peter Attia said he takes rapamycin, calling it probably the single most out-there thing he does — but he has never stated his own dose on air, and the most recent rapamycin material in our corpus is from 2022. The dosing he discusses is weekly rather than daily, from the trial that changed his mind, which tested 5mg and 20mg once-weekly arms.
The trial dosing he points to (2020) — a study's arms, not a recommendation
“there are different ways that you can dose it two of the three treatment arms in that study were only being given rapamycin once a week one at five milligrams one at twenty milligrams”
Peter Attia · Jul 2020 · watch @ 22:20 →
None of the other 4 experts takes a positive position on Rapamycin.
He said so in January 2020, describing it as probably the single most out-there thing he does and arguing he was standing on a large body of animal evidence. That is the most recent statement of personal use in the videos we analyse, and the newest rapamycin material of any kind here is from 2022 — so treat it as what he said then, not as a current protocol.
He does not say in this corpus. The dosing he discusses comes from the trial he credits as his turning point, which gave rapamycin once a week in 5mg and 20mg arms — that is the study's design, not his personal protocol.
The dosing discussed on his show is weekly rather than daily. Weekly dosing is the pattern used in the trial he points to, and the rationale is intermittent rather than continuous mTOR inhibition.
Mouth sores come up most often, and he has hosted extended discussion of the risks of off-label use. He also notes that rapamycin and everolimus are used near-interchangeably in this research.